New Herceptin delivery method could vastly simplify breast cancer treatment
A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published ...
Cancer
Aug 08, 2012 |
not rated yet |
0
Heterogeneous ER+ breast cancer models allow more accurate drug testing
(Medical Xpress) -- Cell cultures are homogeneous. Human tumors are not. A University of Colorado Cancer Center study recently published in the journal Breast Cancer Research and Treatment reports the develo ...
Cancer
Aug 06, 2012 |
5 / 5 (1) |
0
|
Anastrozole and fulvestrant combo better than single drug for metastatic breast cancer
Results of a SWOG clinical trial published August 2 in the New England Journal of Medicine show the combination of anastrozole and fulvestrant extended the median survival time of women with hormone receptor-positive metast ...
Cancer
Aug 01, 2012 |
not rated yet |
0
Researchers find potential cancer roadblock
By identifying a key protein that tells certain breast cancer cells when and how to move, researchers at Michigan State University hope to better understand the process by which breast cancer spreads, or metastasizes.
Cancer
Aug 01, 2012 |
not rated yet |
0
|
Computational analysis identifies drugs to treat drug-resistant breast cancer
Researchers have used computational analysis to identify a new Achilles heel for the treatment of drug-resistant breast cancer. The results, which are published in Molecular Systems Biology, reveal that t ...
Medications
Jul 31, 2012 |
not rated yet |
0
|
Afinitor approved for advanced breast cancer
(HealthDay) -- Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food ...
Medications
Jul 23, 2012 |
not rated yet |
0
Lungs respond to hospital ventilator as if it were an infection
When hospital patients need assistance breathing and are placed on a mechanical ventilator for days at a time, their lungs react to the pressure generated by the ventilator with an out-of-control immune response that can ...
Medical research
Jul 18, 2012 |
5 / 5 (2) |
0
|
Obesity may affect response to breast cancer treatment: study
Women who are obese continue to have higher levels of oestrogen than women of normal weight even after treatment with hormone-suppressing drugs, raising the possibility that they might benefit from changes to their treatment.
Cancer
Jul 16, 2012 |
not rated yet |
0
|
Metastatic breast cancer: Bevacizumab slows progression, but has no impact on survival
The cancer drug bevacizumab (Avastin) offers only a modest benefit in delaying disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed ...
Cancer
Jul 10, 2012 |
not rated yet |
0
'Molecular grenade': Drug from Mediterranean weed kills tumor cells in mice
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by ...
Cancer
Jul 09, 2012 |
5 / 5 (18) |
2
|
Fertility drug usage and cancer risk
Women using fertility drugs who did not conceive a 10-plus week pregnancy were at a statistically significant reduced risk of breast cancer compared to nonusers; however, women using the drugs who conceived a 10-plus week ...
Cancer
Jul 06, 2012 |
not rated yet |
0
In vitro study identifies potential combination therapy for breast cancer
A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro. The findings, published in the July 2012 issue of Anticancer Research, raise ...
Cancer
Jul 02, 2012 |
not rated yet |
0
|
Single protein promotes resistance to widely used anti-estrogen drugs
Researchers at Georgetown Lombardi Comprehensive Cancer Center have uncovered a single molecule they say is a major determinant of resistance to anti-estrogen therapy used to treat or prevent breast cancer in high-risk women.
Cancer
Jul 02, 2012 |
not rated yet |
0
|
New clinical trial design promises to accelerate cancer drug approvals
Patients with early-stage breast cancer usually have to wait years to receive new cancer drugs but new guidance from the Food and Drug Administration (FDA) promises to reduce substantially the time and ...
Cancer
Jun 14, 2012 |
5 / 5 (1) |
0
Combination therapy for triple-negative breast cancer disappointing
(Medical Xpress) -- A recent clinical trial testing a combination therapy for basal-like (also known as triple-negative) breast cancer demonstrates that a combination of two drugs with promising preclinical ...
Cancer
Jun 13, 2012 |
not rated yet |
0
|
